Biggest News Aggregation in the World
๐Ÿ“ฐ Scientific Statement From News

Page 4 - Scientific Statement From News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scientific Statement From. Real-time updates on events, politics, business and more.

Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Associationโ€™s Hypertension journal.
United States Thomas Jefferson University Andrewh Tran Carissam Baker Smith Bonita Falkner Elainem Urbina

AHA Highlights Pediatric Hypertension in Scientific Statement

The latest scientific statement from the American Heart Association takes aim at offering clinicians with a summary of contemporary evidence related to the prevalence and increase in long-term risk associated with hypertension in children and adolescents.
United States Thomas Jefferson University Bonita Falkner Council On Hypertension American Heart Association Bonita Falkner Council On Lifestyle

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Idorsia Pharmaceuticals Ltd: Idorsia submits European marketing authorisation application for aprocitentan for the treatment of patients with resistant hypertension

The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained blood pressure reduction over 48 weeks and was well-tolerated Allschwil
United States Rheinland Pfalz Switzerland General Andrewc Weiss Clozelm Aprocitentan Markus Schlaich

Investegate |Idorsia Pharmaceuticals Ltd Announcements | Idorsia Pharmaceuticals Ltd: Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension

Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia submits a New Drug Application to the US FDA for aprocitentan for the treatment of patients with difficult-to-control hypertension
United States Switzerland General Andrewc Weiss Clozelm Aprocitentan Jean Paul Clozel Markus Schlaich

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science